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Definition
Breast cancer-related lymphoedema (BCRL) is 
a secondary form of lymphoedema and a major 
complication of post-breast cancer surgery 
and radiotherapy. It occurs when the network of 
lymphatic vessels and lymph nodes is damaged by disease, surgery 
or radiotherapy. The lymph, a protein-rich fluid, then accumulates 
in the tissue spaces, which is clinically manifested by swelling of the 
upper limb on the affected side. Sometimes the chest and breast areas 
may also be affected.[1,2] 
Classification and symptoms 
Lymphoedema can be classified into three stages: 
• Stage 1 – subjective feeling of heaviness with or without visible 
swelling
• Stage 2 – visible swelling with pitting and perhaps numbness, 
heaviness, and pain
• Stage 3 – swelling, no pitting, fibrosis, skin changes, heaviness, 
numbness and pain.
If BCRL is not detected and treated in its early stages, it becomes 
chronic and debilitating with severe physical, psychosocial and 
economic implications for the breast cancer survivor’s quality of 
life.[2,3] The physiological factors include recurrent infections, limited 
movement of the limb due to pain, numbness and tenderness. The 
psychosocial factors include social isolation, anxiety, depression, 
and poor self- or body image. The economic factors include loss of 
employment and higher medical costs.[4-8]
Risk factors
After surgery and radiotherapy all breast cancer survivors are at 
risk of developing BCRL despite new surgical techniques to reduce 
its incidence.[1,7-10] The lifetime risk of BCRL among breast cancer 
survivors varies from 33% to 44% and 7% to 44%.[3,9] In addition, if 
lymphoedema is left untreated, it may cause recurrent infections in 
the affected arm, or a generalised systemic infection that may lead to 
death.[1-3,11]
Lymphoedema most commonly occurs in the first three years after 
breast cancer diagnosis and treatment; however, it may occur at any 
stage during the life of a breast cancer survivor.[8,10,11]
Treatment/management 
There is currently no cure for BCRL, but there are international best 
practice guidelines to prevent or reduce its severity.[1] The guidelines 
recommend complete decongestive therapy (CDT), which includes 
gentle massaging known as manual lymph drainage, use of a multilayered 
compression bandage to the affected limb, exercise, and skin/nail care. 
CDT facilitates functioning of the impaired lymphatic system and the 
eventual reduction of lymph volume in the affected upper limb. 
Despite the presence of lymphoedema during or after breast cancer 
surgery, radiotherapy and lymph node dissection, its incidence and 
prevalence may be reduced in most cases if appropriate interventions 
are applied.
International best practice consensus for lymphoedema 
management 
The international recommended treatment of BCRL is CDT, which is 
implemented in most economically developed countries in Europe, 
the USA, certain Asian countries and Australia.[1,2] 
Various research studies have found that BCRL can develop at 
any time after breast cancer diagnosis and treatment. Therefore, 
it is recommended that preoperative and regular postoperative 
assessments of the upper limbs should be done to detect BCRL early. 
This, and immediate intervention, reduces the impact of BCRL on 
the quality of life of the affected breast cancer survivor.[1,3,8]
Complete decongestive therapy
CDT, as the recommended gold standard, involves an initial intensive 
phase lasting 2 - 4 weeks, followed by the maintenance or transition 
phase described below.[1] 
Manual lymph drainage 
Manual lymph drainage (MLD) is a gentle massage technique 
comprising a series of strokes applied directly to the skin. This 
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involves manual manipulation or ‘soft tissue mobilisation’ at a 
superficial and/or deep level of the lymphatic system and aims to 
move fluid away from the congested areas by increasing the activity 
of normal lymph vessels and bypassing ineffective or obliterated 
ducts. A typical session will involve drainage of the neck, trunk 
and involved extremity for 40 - 60 minutes. It is recommended 
that MLD be performed daily during the intensive phase. Before 
embarking on MLD, all possible contraindications must be ruled 
out, including cellulitis, congestive heart failure, renal failure, 
and deep vein thrombosis. Other contraindications may be more 
specific to the patient’s condition and a thorough history is 
therefore essential.[1]
MLD is a specialised therapeutic skill and, although there is a 
wealth of clinical opinion advocating MLD, there is little evidence to 
support its efficacy. MLD is only effective when used in conjunction 
with other components.
Simple lymph drainage (SLD) is a simplified version of MLD that 
patients and healthcarers can be taught to self-administer. This can 
be performed for 10 - 20 minutes daily. SLD can be conducted and 
taught by practitioners with appropriate training.[1]
Multilayered lymphoedema bandaging compression 
therapy 
This involves the use of multilayered lymphoedema bandaging 
(MLLB) and compression garments. Lymphoedema bandaging or 
wrapping is a multilayered system of various sizes of short stretch, 
non-elastic pure cotton bandages applied over cotton padding using 
uniform spacing and tension to create compression around the 
affected area. The purpose of bandaging following MLD is to reduce 
the return of lymph to the affected area and to enhance increased 
lymph flow. Foam is often used in the layering to reduce fibrosis and 
increase comfort. During the intensive phase it is recommended that 
bandages be changed daily for the first 7 days and then be reduced 
to 2 - 3 times per week, depending on the progress. Self-bandaging 
or bandaging by a caregiver is also recommended if there is limited 
access to a skilled therapist. 
Once adequate reduction of the affected limb is obtained, 
compression garments are applied to maintain the reduction. 
Garments can be custom-made or ready to use (off the shelf). Persons 
living with lymphoedema often wear the garments during the day 
and alternate these with bandaging at night during the maintenance 
phase of the intervention. Compression garments are essential for 
long-term improvement and assist with patient compliance. They 
can also be used prophylactically to prevent the progression of 
lymphoedema.
Garments can be categorised according to fabric construction (i.e. 
circular or flat knit) and the pressures exerted (Classes I - IV). The 
compression hosiery standards vary between different countries.[1]
Assessment and measurement of garments require that the 
caregiver or healthcare practitioner has specialist training or access 
to a lymphoedema specialist.[1]
Exercise
Exercise through the use of muscle contraction and deep breathing 
increases lymphatic flow and is most effective in conjunction with 
short stretch bandaging or compression garments. Exercise programmes, 
differing in frequency and intensity, are indicated for individuals with 
lymphoedema and for those at risk. Exercise can be categorised as 
lymphoedema exercise (non-resistive active motion of the affected limb), 
stretching (reducing tightness/scarring), resistive exercise (progressive 
weight resistance – this type poses the greatest risk) and aerobic conditioning 
(improving cardiovascular fitness). It should be noted that exercise alone 
will not reduce limb volume effectively and that any programme should be 
carefully explained and tailored to the individual’s needs.[1]
Skin care of the affected limb
Maintenance of skin integrity and careful management of 
dermatological problems are important to minimise the risk of 
infection. The principles of skin care include:[1]
• Daily washing with a pH-neutral soap, natural soap or soap 
substitute and drying thoroughly.
• Ensuring that skin folds, if present, are clean and dry.
• Monitoring affected and unaffected skin for cuts, abrasions or 
insect bites, paying particular attention to areas affected by sensory 
neuropathy.
• Application of emollients.
• Avoidance of scented products, particularly in hot climates. 
Vegetable-based products are preferable to those containing 
petrolatum or mineral oils.
Self-management
Self-management is highly dependent on compliance and the 
individual’s resources and support system. Self-management by the 
individual/caregiver involves education and training on massaging 
(SLD), bandaging, exercising and skin/nail care. As lymphoedema 
is a chronic condition, those affected by it have to master life-long 
management. Consistency is essential during self-management and 
therapeutic support is offered intermittently.[1] 
Challenges facing the management of 
BCRL in South Africa
There are no official BCRL guidelines or protocols in the South 
African healthcare system. A skills gap exists in terms of the number 
of lymphoedema therapists in the public and private healthcare 
systems. Therefore, an accessible and effective service for those with 
the condition and at risk is lacking. 
According to the newly established Lymphoedema Association of 
South Africa (LAOSA), there are approximately 67 lymphoedema 
therapists in South Africa. Fewer than 10% of them are currently working 
in the public sector. With the increased incidence of breast cancer 
and longer survival rates (>5 years), the demand for lymphoedema 
treatment is steadily growing. Awareness of the condition is probably 
the major stumbling block in the healthcare system. The number of 
trained therapists cannot support or sustain a service according to the 
recommended gold standard method. Private lymphoedema therapists 
outnumber those in the public sector, where the majority of patients 
seek help. Budgetary constraints in terms of sourcing bandages and 
garments also hinder the implementation of gold standard management. 
Additionally, the socioeconomic status of patients makes it difficult to 
attend therapeutic sessions as often as recommended owing to financial 
hardship. Private patients receive little support from medical aids, some 
of which are only now starting to consider covering CDT treatment and 
only by certain categories of professionals.
Conclusion
The recommended international best practice guidelines cannot be 
implemented at all levels of care in the South African public and 
private healthcare sectors owing to the paucity of healthcare providers 
with the requisite skills to manage BCRL. In addition, the compression 
garments and bandages are very costly and rarely available in the public 
healthcare sector. Most medical aids do not provide full reimbursement 
for the cost of these commodities. Against this backdrop BCRL referral 
and management guidelines and other recommendations are proposed 
for South Africa (Tables 1 and 2).  
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Table 1. Referral pathway guideline within and from the various levels of care
Level of care Guideline
Level 3/level 2: tertiary/secondary hospital (public health) All newly diagnosed patients to hospital-based lymphoedema service for BCRL 
information and pre-treatment measurements of limbs 
Patients with BCRL symptoms to lymphoedema service for assessment and 
treatment plan
Level 1: primary level clinics, community healthcare centres Patients with BCRL symptoms to lymphoedema trained clinical staff for 
assessment and management and to home-based carer/rehabilitation careworker 
to provide support within the community
BCRL = breast cancer-related lymphoedema.
Table 2. Staging and management of  breast cancer-related lymphoedema 
Stage of lymphoedema Treatment/management
Stage1: feeling of heaviness only, accompanied by slight swelling Symptoms relieved by elevation of the limb, exercise, compression garment if 
slight swelling persists 
Stage 2: visible swelling and pitting, with/without hardening of 
the skin, slight change in skin texture
Encourage exercise of limb, manual lymph drainage/simple lymph drainage, 
skin care, exercise, use of multilayer compression bandaging  
Stage 3: visible swelling, no pitting, fibrosis, skin changes Encourage exercise of limb, manual lymph drainage/simple lymph drainage, 
skin care, exercise, multilayered lymphoedema bandaging 
Recommendations
1. All newly diagnosed patients and those with BCRL symptoms should be referred appropriately.
2. Patients who present with various stages of BCRL should be managed appropriately.
Managing BCRL is very intense and could become cumbersome for the therapist, caregiver and affected person. It is therefore important to 
keep the patient motivated. The treatment plan should be unique to each individual.
3.  National Department of Health (NDoH) to facilitate development of a breast health-cancer policy that includes BCRL management 
guidelines. 
4.  NDoH to facilitate integration of BCRL management guidelines into the chronic diseases directorate policy, as lymphoedema is a chronic 
condition.
5.  BCRL epidemiology and management to be integrated into training curricula of healthcare professionals and rehabilitation careworkers 
(RCWs)/home-based carers (HBCs).
6. Research to be conducted to inform the development of BCRL treatment protocols in South Africa.
7.  An integrated team approach, which includes oncologists, surgeons, nurses, doctors, physiotherapists, occupational therapists, social 
workers, RCWs/HBCs and, most importantly, the individual at risk of/experiencing BCRL.
8. The development of lymphoedema packages of care/treatment guidelines for different levels of care suited to South Africa.
